Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using same
US8623417B1 · kind B1 · utility
18Cited by
30References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 2013 |
| Grant date | Jan 7, 2014 |
| Priority date | — |
| Expiry date | Jun 5, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/773
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure generally relates to therapeutic nanoparticles. Exemplary nanoparticles disclosed herein may include about 1 to about 20 weight percent of a mTOR inhibitor; and about 70 to about 99 weight percent biocompatible polymer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.